Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cancer Pain × resiniferatoxin × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Intractable 1 Pain 1 Cancer Pain 1

Interventions

Morphine 2 resiniferatoxin 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 alvimopan 1 Surveys and Questionnaires 1 Standard of Care 1 Pain Management 1 Oxycodone 1 Massage 1 Lidocaine 1 Lenalidomide 1 Ketamine 1 Gels 1 Fentanyl 1 Dronabinol 1 Cannabidiol 1 Animal Assisted Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05067257 2024-03-18

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Sorrento Therapeutics, Inc.

Phase 2 Suspended

Cancer Pain, Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡